Updated: March 29, 2021 Bio Farma to operate new vaccine production facility in April Must Read Nationalindonesianupdates.com_admin - February 6, 2025School revitalization to also target private schools: govt Nationalindonesianupdates.com_admin - February 6, 2025Navy mulls purchase of aircraft carrier for non-war operations Nationalindonesianupdates.com_admin - February 6, 2025Indonesia plans to extradite Reynhard Sinaga to Nusakambangan State-run vaccine producer PT Bio Farma (Persero) will start operating its new production facility in April to boost the manufacturing of COVID-19 vaccines. President Director of PT Bio Farma Honesti Basyir remarked that the … Previous articleBalongan refinery fire inflicts 400,000 barrels oil loss for PertaminaNext articleVaccination, mobility restriction effectively cut COVID-19 infections Latest News National - February 6, 2025School revitalization to also target private schools: govtThe government has assured that its school revitalization program will not only target public schools but also private ... National Navy mulls purchase of aircraft carrier for non-war operations - February 6, 2025 National Indonesia plans to extradite Reynhard Sinaga to Nusakambangan - February 6, 2025 National Govt explores development of Maung Pindad electric version - February 6, 2025 National Hasto offered position to lawmaker for Masiku election: KPK - February 6, 2025 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
State-run vaccine producer PT Bio Farma (Persero) will start operating its new production facility in April to boost the manufacturing of COVID-19 vaccines.